Re: Zenith Q4 2017 Events

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Q4 2017 Events

posted on Nov 13, 2017 10:30AM

"IMO there is a Zenith offering coming up"

That sounds like a reasonable expectation, since both the October and November Zenith presentations included on slide 3 "10MM additional shares will be sold shortly."

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply